InvestorsHub Logo
Followers 14
Posts 1446
Boards Moderated 0
Alias Born 02/28/2011

Re: Spideyboy post# 2294

Friday, 01/06/2017 1:43:34 PM

Friday, January 06, 2017 1:43:34 PM

Post# of 3353
Spideyboy - interesting piece of information and thanks for pointing that out. I went back to BCLI's website and read the news. here is it for anyone who wants to review it.

http://ir.brainstorm-cell.com/phoenix.zhtml?c=142287&p=RssLanding&cat=news&id=2234205

in my opinion, I feel it contradicts what Chaim Lebovits said during their year end conference call. I remember that distinctly because I was surprised the company wasn't going to raise capital or seek it in other areas to fund Phase 3. my initial impression was that Chaim was already in discussion with investor(s) or other means to fund Phase 3 without adding debt. I was very pleased to hear that from them. however, this latest news about the company attending this biotech conference does raise a little concern for the short term. Maybe an investor backed out since the year end call and the company is looking for others? or maybe dilutive capital is their backup plan? idk, we can speculate all we want but I personally feel, it's nothing to get worked up about. my position is that I'm here for the long term so if they have to dilute stock to fund some of their Phase 3, so be it. I'll just buy more stock. why im not too concerned is because of the company's product and their results. I strongly feel this will get FDA approval in the future because it benefits ALS patients now. Their phase 3 trial with 150(+/-) patients who they're looking to enroll will have positive results as phase 2 did.

I would be more concerned if their product was bad and they have to go back to the drawing board and their saving grace was to attend investor conferences.. since this is isn't the case, I wouldn't worry to much about it. yes, funding phase 3 is a concern of mine but I feel they have the means and haven't discussed it yet.

of course all of this is my opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCLI News